<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Linke, Axel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">CLEAN-TAVI: Less Radiological Evidence of Stroke in Patients Treated with TAVR Plus a Cerebral Embolic Filter</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-11</style></pages><abstract><style  face="normal" font="default" size="100%">Stroke is a major complication following transcatheter aortic valve replacement (TAVR) that increases mortality by &gt;3.5 fold [Eggebrecht H et al. EuroIntervention. 2012]. The Claret Montage dual-filter Cerebral Protection System was developed to protect the brain from injury caused by embolic debris. The Claret Embolic Protection and Transcatheter Aortic Valve Implantation Trial [CLEAN-TAVI; NCT01833052] evaluated the impact of the use of this filter on the number of cerebral lesions in high-risk, aortic stenosis patients undergoing TAVR using the Medtronic CoreValve.</style></abstract><number><style face="normal" font="default" size="100%">30</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>